Program: General Sessions
Session: Ham-Wasserman Lecture
Session: Ham-Wasserman Lecture
Saturday, December 5, 2020, 2:00 PM-3:00 PM
Disclosures: Roberts: Servier: Research Funding; AbbVie: Research Funding; Genentech: Patents & Royalties: for venetoclax to one of my employers (Walter & Eliza Hall Institute); I receive a share of these royalties; Janssen: Research Funding.
OffLabel Disclosure: I will be discussing results of trials investigating venetoclax in several hematological malignancies, including multiple where the drug does not have a label.